These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31629413)

  • 1. Urology perspective on the expanding world of germline testing for prostate cancer.
    Cookson MS
    Can J Urol; 2019 Oct; 26(5 Suppl 2):5-6. PubMed ID: 31629413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline testing for prostate cancer: community urology perspective.
    Concepcion RS
    Can J Urol; 2019 Oct; 26(5 Suppl 2):50-51. PubMed ID: 31629433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline testing in those at risk of prostate cancer.
    Carroll PR; Witte JS; Parsons JK
    Can J Urol; 2019 Oct; 26(5 Suppl 2):31-33. PubMed ID: 31629425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations of germline testing in prostate cancer screening.
    Polascik TJ; Orabi H
    Can J Urol; 2019 Oct; 26(5 Suppl 2):46-47. PubMed ID: 31629431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling perspective of engagement with urology and primary care.
    Hyatt C; Russo J; McDougall C
    Can J Urol; 2019 Oct; 26(5 Suppl 2):52-53. PubMed ID: 31629434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice.
    Giri VN; Hyatt C; Leader A
    J Urol; 2020 Dec; 204(6):1116-1118. PubMed ID: 32926644
    [No Abstract]   [Full Text] [Related]  

  • 7. Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management.
    Giri VN; Hyatt C; Gomella LG
    J Clin Oncol; 2019 Jun; 37(17):1455-1459. PubMed ID: 30978156
    [No Abstract]   [Full Text] [Related]  

  • 8. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS
    J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
    Szymaniak BM; Facchini LA; Giri VN; Antonarakis ES; Beer TM; Carlo MI; Danila DC; Dhawan M; George D; Graff JN; Gupta S; Heath E; Higano CS; Liu G; Molina AM; Paller CJ; Patnaik A; Petrylak DP; Reichert Z; Rettig MB; Ryan CJ; Taplin ME; Vinson J; Whang YE; Morgans AK; Cheng HH; McKay RR
    JCO Oncol Pract; 2020 Dec; 16(12):811-819. PubMed ID: 32986533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline testing for prostate cancer prognosis: implications for active surveillance.
    Helfand BT; Xu J
    Can J Urol; 2019 Oct; 26(5 Suppl 2):48-49. PubMed ID: 31629432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline genetics in localized prostate cancer.
    Ryan ST; Nguyen V; Bree KK; Holst DD; Kader AK
    Curr Opin Urol; 2019 Jul; 29(4):326-333. PubMed ID: 31116139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations of multigene test findings among men with prostate cancer - knowns and unknowns.
    AlDubayan SH
    Can J Urol; 2019 Oct; 26(5 Suppl 2):14-16. PubMed ID: 31629418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights into the germline for prostate cancer initiation, progression, and aggressiveness.
    Pritchard CC
    Can J Urol; 2019 Oct; 26(5 Suppl 2):24-26. PubMed ID: 31629422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to use germline genetic testing in prostate cancer.
    Giri VN
    Clin Adv Hematol Oncol; 2022 Feb; 20(2):78-81. PubMed ID: 35120087
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate Cancer Genomic Testing: When Sequencing Is Not Sufficient and Germline Testing Is Necessary.
    Jacobs MF; Greenberg SE
    Eur Urol; 2023 Jan; 83(1):39-40. PubMed ID: 36208965
    [No Abstract]   [Full Text] [Related]  

  • 16. Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
    Cheng H; Powers J; Schaffer K; Sartor O
    Am Soc Clin Oncol Educ Book; 2018 May; 38():372-381. PubMed ID: 30231311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
    J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Multigene Testing for Prostate Cancer.
    Berro T; Barrett E; AlDubayan SH
    Urol Clin North Am; 2021 Aug; 48(3):297-309. PubMed ID: 34210486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
    Paller CJ; Barata PC; Lorentz J; Appleman LJ; Armstrong AJ; DeMarco TA; Dreicer R; Elrod JAB; Fleming M; George C; Heath EI; Hussain MHA; Mao S; McKay RR; Morgans AK; Orton M; Pili R; Riedel E; Saraiya B; Sigmond J; Sokolova A; Stadler WM; Tran C; Macario N; Vinson J; Green R; Cheng HH;
    Prostate; 2024 Feb; 84(3):292-302. PubMed ID: 37964482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for hereditary prostate cancer: Current status and limitations.
    Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
    Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.